SAFETY AND EFFICACY OF SORAFENIB FOR ADVANCED HEPATOCELLULAR CARCINOMA

被引:0
|
作者
Sacco, P. C. [1 ]
De Sanctis, R. [1 ]
Quadrini, S. [1 ]
Gori, B. [1 ]
Del, Signore E. [1 ]
Stumbo, L. [1 ]
Tedeschi, M. [1 ]
Falbo, P. T. [1 ]
Fulvi, A. [1 ]
Grassi, P. [1 ]
Sollami, R. [1 ]
Basile, M. L. [1 ]
Di Seri, M. [1 ]
机构
[1] Policlin Umberto 1, Rome, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Efficacy and safety of sorafenib in patients aged 80 years and older with advanced hepatocellular carcinoma
    Yasui, Kohichiroh
    Jo, Masayasu
    Nishimura, Takeshi
    Yamaguchi, Kanji
    Sumida, Yoshio
    Mitsuyoshi, Hironori
    Minami, Masahito
    Itoh, Yoshito
    [J]. HEPATOLOGY, 2013, 58 : 1256A - 1257A
  • [12] The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study
    Wada, Yoshiyuki
    Takami, Yuko
    Matsushima, Hajime
    Tateishi, Masaki
    Ryu, Tomoki
    Yoshitomi, Munehiro
    Matsumura, Taisei
    Saitsu, Hideki
    [J]. INTERNAL MEDICINE, 2018, 57 (10) : 1345 - 1353
  • [14] Safety and efficacy of sorafenib in patients with Child-Pugh B advanced hepatocellular carcinoma
    Da Fonseca, Leonardo Gomes
    Barroso-Sousa, Romualdo
    Alves Bento, Afonso Da Silva
    Blanco, Bruna Paccola
    Valente, Gabriel Luis
    Flesch Pfiffer, Tulio Eduardo
    Hoff, Paulo Marcelo
    Sabbaga, Jorge
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2015, 3 (04) : 793 - 796
  • [15] Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
    Bruix, Jordi
    Raoul, Jean-Luc
    Sherman, Morris
    Mazzaferro, Vincenzo
    Bolondi, Luigi
    Craxi, Antonio
    Galle, Peter R.
    Santoro, Armando
    Beaugrand, Michel
    Sangiovanni, Angelo
    Porta, Camillo
    Gerken, Guido
    Marrero, Jorge A.
    Nadel, Andrea
    Shan, Michael
    Moscovici, Marius
    Voliotis, Dimitris
    Llovet, Josep M.
    [J]. JOURNAL OF HEPATOLOGY, 2012, 57 (04) : 821 - 829
  • [16] Efficacy and safety of sorafenib plus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
    Regmi, Parbatraj
    Hu, Hai-Jie
    Lv, Tian-Run
    Paudyal, Aliza
    Sah, Ram Babu
    Ma, Wen-Jie
    Jin, Yan-Wen
    Li, Fu-Yu
    [J]. SURGICAL ONCOLOGY-OXFORD, 2021, 39
  • [17] Efficacy of Sorafenib for Advanced Hepatocellular Carcinoma and Prognostic Factors
    Li, Jinpeng
    Wang, Lijun
    Cong, Ning
    Shi, Congcong
    Bu, Wenzhe
    Song, Jinlong
    Chen, Hua
    [J]. HEPATO-GASTROENTEROLOGY, 2014, 61 (132) : 954 - 957
  • [18] Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma
    Nakano, Masahito
    Tanaka, Masatoshi
    Kuromatsu, Ryoko
    Nagamatsu, Hiroaki
    Sakata, Kenji
    Matsugaki, Satoru
    Kajiwara, Masahiko
    Fukuizumi, Kunitaka
    Tajiri, Nobuyoshi
    Matsukuma, Norito
    Sakai, Terufumi
    Ono, Noriyuki
    Yano, Yoichi
    Koga, Hironori
    Kurogi, Junichi
    Takata, Akio
    Sumie, Shuji
    Satani, Manabu
    Yamada, Shingo
    Niizeki, Takashi
    Aino, Hajime
    Iwamoto, Hideki
    Torimura, Takuji
    Sata, Michio
    [J]. ONCOLOGY, 2013, 84 (02) : 108 - 114
  • [19] Indicators of sorafenib efficacy in patients with advanced hepatocellular carcinoma
    Yada, Masayoshi
    Masumoto, Akihide
    Motomura, Kenta
    Tajiri, Hirotaka
    Morita, Yusuke
    Suzuki, Hideo
    Senju, Takeshi
    Koyanagi, Toshimasa
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (35) : 12581 - 12587
  • [20] Efficacy and safety of a phase II study of sorafenib plus gemcitabine in advanced hepatocellular carcinoma.
    Srimuninnimit, V.
    Sriuranpong, V.
    Suwanvecho, S.
    Soparattanapaisarn, N.
    Ithimakin, S.
    Akewanlop, C.
    Tanasanvimon, S.
    Parinyanitikul, N.
    Kiatikajornthada, N.
    Suwanrusme, H.
    Chaiyarat, W.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)